Is overnight incorporation of [1-13C]-phenylalanine amino acids higher in muscle tissue in combination with NMES than in unstimulated skeletal muscle?
ID
Bron
Verkorte titel
Aandoening
Sarcopenia, muscle mass, protein, Neuromuscular electrostimulation
Ondersteuning
Maastricht University
Department of Human Movement Sciences
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Primary parameter of this study will be overnight incorporation of stable isotope amino acids from the intrinsically labeled drink.
Achtergrond van het onderzoek
Rationale:
With human aging there is a gradual but progressive decline in skeletal muscle mass, termed sarcopenia. While the underlying cause of sarcopenia is likely to be multifaceted, a primary factor is that elderly individuals frequently experience short periods of muscle disuse following limb immobilization or bed-rest (due to injury or illness) causing rapid muscle loss. Feasible strategies for maintaining muscle protein synthesis rates in elderly individuals, and thus having the potential to attenuate the loss of muscle mass during disuse need to be pursued. Local neuromuscular electrical stimulation (NMES) in combination with additional intake of protein offer such a potential strategy but, as yet, remains relatively unexplored.
Objective:
To test the hypothesis that ingesting a nocturnal bolus of protein in combination with NMES stimulates muscle protein synthesis in elderly more than ingesting protein without NMES.
Study design:
Prospective, single blind, intervention study.
Intervention:
Consumption of a 40 g bolus of intrinsically L[1-13C]-phenylalanine labeled casein protein and 70 min of one-legged NMES.
Endpoints:
Enrichments of muscle tissue after ingestion of an [1-13C]-phenylalanine intrinsically labeled casein drink.
Doel van het onderzoek
Is overnight incorporation of [1-13C]-phenylalanine amino acids higher in muscle tissue in combination with NMES than in unstimulated skeletal muscle?
Onderzoeksopzet
Overnight (i.e. the morning after ingestion of the stable isotope drink and NMES). Method of measurement is massaspectrometry.
Onderzoeksproduct en/of interventie
Consumption of a 40 g bolus of intrinsically L[1-13C]-phenylalanine labeled casein protein and 70 min of one-legged NMES.
Publiek
Wetenschappelijk
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Written informed consent;
2. Age ≥ 65 years;
3. Male.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Type II diabetes;
2. All co morbidities interacting with mobility and muscle metabolism of the lower limbs (e.g. arthrosis, arthritis, spasticity/rigidity, all neurological disorders, paralysis, hip/knee surgery);
3. Use of anticoagulants, blood diseases, allergy for lidocain;
4. Use of NSAIDs and acetylsalicylic acid;
5. Patients suffering from PKU (Phenylketonuria);
6. Presence of implantable cardioverter defibrillator and/or pacemaker;
7. Performed regular resistance type exercise in the past 6 months;
8. Use of any tools to assist during walking (cane/ crutches/ walker);
9. (Partial) foot/ leg amputation.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL3786 |
NTR-old | NTR3952 |
Ander register | ABR / METC MUMC : 44582 / 13-3-024; |
ISRCTN | ISRCTN wordt niet meer aangevraagd. |